Colgate-Palmolive (NYSE:CL) Shares Acquired by Oakworth Capital Inc.

Oakworth Capital Inc. lifted its stake in Colgate-Palmolive (NYSE:CL) by 90.0% in the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 2,955 shares of the company’s stock after purchasing an additional 1,400 shares during the quarter. Oakworth Capital Inc.’s holdings in Colgate-Palmolive were worth $236,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors have also recently bought and sold shares of the company. Vest Financial LLC lifted its stake in Colgate-Palmolive by 25.1% in the 4th quarter. Vest Financial LLC now owns 370,071 shares of the company’s stock worth $29,498,000 after acquiring an additional 74,337 shares in the last quarter. Central Bank & Trust Co. grew its stake in Colgate-Palmolive by 22.1% in the fourth quarter. Central Bank & Trust Co. now owns 1,383 shares of the company’s stock valued at $110,000 after purchasing an additional 250 shares in the last quarter. Dynamic Advisor Solutions LLC increased its position in Colgate-Palmolive by 9.2% in the 4th quarter. Dynamic Advisor Solutions LLC now owns 10,808 shares of the company’s stock worth $864,000 after purchasing an additional 910 shares during the last quarter. Sarasin & Partners LLP raised its stake in shares of Colgate-Palmolive by 1.2% during the 4th quarter. Sarasin & Partners LLP now owns 4,053,634 shares of the company’s stock worth $323,115,000 after purchasing an additional 49,980 shares in the last quarter. Finally, Cornerstone Wealth Management LLC lifted its holdings in shares of Colgate-Palmolive by 2.5% during the 4th quarter. Cornerstone Wealth Management LLC now owns 7,170 shares of the company’s stock valued at $571,000 after buying an additional 172 shares during the last quarter. Hedge funds and other institutional investors own 80.41% of the company’s stock.

Colgate-Palmolive Price Performance

Shares of CL stock opened at $86.77 on Thursday. Colgate-Palmolive has a 12 month low of $67.62 and a 12 month high of $90.37. The company has a market capitalization of $71.32 billion, a P/E ratio of 31.21, a P/E/G ratio of 3.24 and a beta of 0.42. The stock has a 50 day moving average of $86.97 and a two-hundred day moving average of $80.63. The company has a current ratio of 1.11, a quick ratio of 0.71 and a debt-to-equity ratio of 8.59.

Colgate-Palmolive (NYSE:CL) last issued its earnings results on Friday, January 26th. The company reported $0.87 EPS for the quarter, topping the consensus estimate of $0.85 by $0.02. The firm had revenue of $4.95 billion during the quarter, compared to analysts’ expectations of $4.89 billion. Colgate-Palmolive had a return on equity of 509.75% and a net margin of 11.82%. Colgate-Palmolive’s quarterly revenue was up 6.9% compared to the same quarter last year. During the same period last year, the business earned $0.77 earnings per share. As a group, equities analysts expect that Colgate-Palmolive will post 3.49 EPS for the current year.

Colgate-Palmolive Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, May 15th. Stockholders of record on Monday, April 22nd will be given a dividend of $0.50 per share. This is a positive change from Colgate-Palmolive’s previous quarterly dividend of $0.48. This represents a $2.00 annualized dividend and a dividend yield of 2.30%. The ex-dividend date is Friday, April 19th. Colgate-Palmolive’s payout ratio is 69.06%.

Wall Street Analyst Weigh In

A number of equities analysts recently commented on CL shares. Citigroup increased their price objective on Colgate-Palmolive from $95.00 to $100.00 and gave the stock a “buy” rating in a report on Tuesday. StockNews.com downgraded shares of Colgate-Palmolive from a “strong-buy” rating to a “buy” rating in a report on Tuesday, February 20th. Morgan Stanley upped their price objective on shares of Colgate-Palmolive from $85.00 to $93.00 and gave the stock an “overweight” rating in a report on Monday, January 29th. TheStreet raised shares of Colgate-Palmolive from a “c+” rating to a “b+” rating in a research report on Friday, January 26th. Finally, The Goldman Sachs Group initiated coverage on Colgate-Palmolive in a research report on Friday, March 1st. They set a “buy” rating and a $93.00 target price for the company. Three analysts have rated the stock with a hold rating and thirteen have given a buy rating to the stock. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average target price of $89.50.

Insider Activity at Colgate-Palmolive

In other Colgate-Palmolive news, CEO Noel R. Wallace sold 29,772 shares of Colgate-Palmolive stock in a transaction that occurred on Friday, February 16th. The stock was sold at an average price of $84.06, for a total transaction of $2,502,634.32. Following the sale, the chief executive officer now directly owns 301,343 shares of the company’s stock, valued at $25,330,892.58. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. In other Colgate-Palmolive news, CEO Noel R. Wallace sold 29,772 shares of the stock in a transaction on Friday, February 16th. The stock was sold at an average price of $84.06, for a total transaction of $2,502,634.32. Following the completion of the transaction, the chief executive officer now directly owns 301,343 shares in the company, valued at $25,330,892.58. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, insider Jennifer Daniels sold 61,633 shares of the business’s stock in a transaction on Thursday, February 1st. The shares were sold at an average price of $83.93, for a total transaction of $5,172,857.69. Following the completion of the sale, the insider now owns 57,948 shares in the company, valued at approximately $4,863,575.64. The disclosure for this sale can be found here. Insiders have sold a total of 232,371 shares of company stock valued at $19,505,099 over the last quarter. 0.34% of the stock is owned by company insiders.

Colgate-Palmolive Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.